BiofuturaFarma

Biofutura is an Italian pharmaceutical company that operates as a specialized subsidiary of the Alfasigma group. The company focuses on the development and commercialization of therapeutic solutions for rare diseases, metabolic disorders, and neurological conditions. Historically established as part of the Sigma-Tau Group, Biofutura has built a significant presence in the Italian market with a portfolio centered on carnitine-based treatments and specialized primary care products. Its business model integrates the delivery of prescription medicines with high-quality nutraceuticals to address unmet medical needs in niche therapeutic areas. Biofutura leverages the extensive research and manufacturing infrastructure of its parent company, Alfasigma, to provide innovative healthcare solutions primarily within the European market.